Department Of Neurology 5

201. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
202. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
203. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
204. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
205. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
206. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
207. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
208. Biochemical and neurological changes post-COVID-19: A focus on oxidative metabolism – A case–control study
209. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
210. Telerehabilitation: lessons from the COVID-19 pandemic and future perspectives
211. Vagus nerve stimulation as a therapeutic option in inflammatory rheumatic diseases
212. Association between COVID-19 and catatonia manifestation in two adolescents in Central Asia: Incidental findings or cause for alarm?
213. Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimers Disease
214. Neuropsychological Assessment of Community-Dwelling Older Adults in Almaty, Kazakhstan
215. Commentary: GM1-Gangliosidosis Type III Associated Parkinsonism
216. Commentary: GM1-Gangliosidosis Type III Associated Parkinsonism
217. Commentary: GM1-Gangliosidosis Type III Associated Parkinsonism
218. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients
219. Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients
220. Corrigendum: Functional MRI study of feedback-based reinforcement learning in depression (Frontiers in Neuroinformatics, (2022), 16, (1028121), 10.3389/fninf.2022.1028121)
221. Functional MRI study of feedback-based reinforcement learning in depression
222. Prevalence of migraine in individuals with functional seizures: A systematic review and meta-analysis
223. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
224. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
225. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
226. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
227. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
228. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
229. Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countries
230. Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countries
231. Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countries
232. Brain health and national neurological societies: Results of the European Academy of Neurology survey on brain health awareness and areas of implementation for European countries
233. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
234. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
235. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
236. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
237. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
238. Does COVID-19 contribute to development of neurological disease?
239. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
240. Evaluation of Branched-Chain Amino Acids in Children with Autism Spectrum Disorder and Epilepsy
241. Changes in prehospital stroke care and stroke mimic patterns during the covid-19 lockdown
242. Changes in prehospital stroke care and stroke mimic patterns during the covid-19 lockdown
243. The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050
244. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
245. Translation of nurse-initiated protocols to manage fever, hyperglycaemia and swallowing following stroke across Europe (QASC Europe): A pre-test/post-test implementation study
246. Differences in acute ischemic stroke treatment: A cross-sectional study from international Registry of Stroke Care Quality (RES-Q)
247. Predictors associated with night sleep disturbance among breastfeeding women
248. Practices, Resources and Challenges in Parkinsons Disease Management in Asia: Movement Disorders in Asia Study Group Report
249. Practices, Resources and Challenges in Parkinsons Disease Management in Asia: Movement Disorders in Asia Study Group Report
250. Practices, Resources and Challenges in Parkinsons Disease Management in Asia: Movement Disorders in Asia Study Group Report
1 3 4 5 6 7 13